Product Information
COBENFY 50 MG-20 MG CAPSULE is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $30.2388 per EA under NDC 00003005060. Its NADAC has been published 75 times since Mar 19, 2025.
FDA first approved this application on Sep 26, 2024.
Strength
20; 50 mg/1; mg/1
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003005060
Classification
Brand
Dosage Form
CAPSULE, COATED PELLETS
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TROSPIUM CHLORIDE; XANOMELINEApproval Type
New Drug (NDA)
FDA Application
NDA216158FDA Approved
9/26/2024
On Market Since
9/27/2024
Pharmacological Classes
Price Statistics
The NADAC for COBENFY 50 MG-20 MG CAPSULE has been published 75 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $30.2388 per EA |
|---|---|
| All-time high | $30.3045 (May 13, 2026) |
| All-time low | $29.6272 (Apr 23, 2025) |
| 52-week high | $30.3045 |
| 52-week low | $29.6552 |
| Median price | $29.7389 |
| Average price | $29.9463 |
| Largest weekly change | +2.0% (Jan 14, 2026) |
| Weeks tracked | 75 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the xanomeline and trospium chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COBENFY 50 MG-20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for COBENFY 50 MG-20 MG CAPSULE, manufactured by E.R. Squibb & Sons, L.L.C., is $30.2388 per EA (NDC 00003005060), effective Aug 19, 2026.
How has the price of COBENFY 50 MG-20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for COBENFY 50 MG-20 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for COBENFY 50 MG-20 MG CAPSULE?
Since Mar 19, 2025, the NADAC for COBENFY 50 MG-20 MG CAPSULE has ranged from a low of $29.6272 (Apr 23, 2025) to a high of $30.3045 (May 13, 2026), with a median of $29.7389 per EA.
Are there cheaper alternatives to COBENFY 50 MG-20 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of COBENFY 50 MG-20 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COBENFY 50 MG-20 MG CAPSULE?
COBENFY 50 MG-20 MG CAPSULE (NDC 00003005060) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.